Nucleic Acid Testing: A Vehicle for Advancing Personalized MedicineDecision ResourcesApril 17, 2009 29 Pages - SKU: DECR2219118 |
|
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development,
|
more...
|
$3,795.00
|
|
IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics)
3/3/2012 | published by: Kalorama Information
What does the diagnostic market look like today, how is the continuing economic news effecting the market, and what are companies doing right now to prosper? This diagnostic industry market research bundle, with over
|
more...
|
$5,995.00
|
|
Companion Diagnostics - Increased Focus on Personalized Medicine and Favorable Regulatory Environment to Drive Market Growth
3/27/2012 | published by: GlobalData
Companion Diagnostics - Increased Focus on Personalized Medicine and Favorable Regulatory Environment to Drive Market Growth Summary GlobalData’s report, “Companion Diagnostics - Increased Focus on Personalized Medicine and Favorable Regulatory Environment to Drive Market Growth”, provides information
|
more...
|
$500.00
|
|
Personalized Medicine Partnering Terms and Agreements, 3rd Edition
4/1/2012 | published by: CHI Insight Pharma Reports
Personalized Medicine Partnering Terms and Agreements provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies
Trends in personalized medicine
|
more...
|
$4,995.00
|
|
The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition
1/1/2012 | published by: Kalorama Information
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at
|
more...
|
$3,500.00
|
|
Genetic Testing
2/1/2012 | published by: Global Industry Analysts
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive testing. The report provides separate
|
more...
|
$4,500.00
|
|
Personalized Medicine Market Analysis
1/1/2012 | published by: RNCOS
With the increasing knowledge of human DNA, a new segment called personalized medicines has emerged in the healthcare industry, which includes therapeutics, diagnostics, and theranostics tailored towards the treatment or prevention of disease. Even though
|
more...
|
$1,200.00
|
|
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
1/9/2012 | published by: GlobalData
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Summary GlobalData’s new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on
|
more...
|
$2,500.00
|
|
Companion Diagnostics in Personalized Medicine and Cancer Therapy
2/1/2012 | published by: TriMark Publications
Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome
|
more...
|
$3,400.00
|
|
Gene Amplification Technologies
2/1/2012 | published by: Global Industry Analysts
This report analyzes the worldwide markets for Gene Amplification Technologies in US$ Million by the following Product Segments: Polymerase Chain Reaction, and Other Gene Amplification Technologies. The report provides separate comprehensive analytics for the US,
|
more...
|
$4,500.00
|
Related Markets
Molecular Assays Reports
- Cell-Based Assays
- Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
- Biochips for Life Science Research, Diagnostics and Drug R&D
- Nucleic Acid Amplification Life Science Dashboard™ Series 2
- Strategic Analysis of the European Markets for Theranostics
